Sara C. Murphy
Impact in
-
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- RNA modifications and cancer
- Cell death mechanisms and regulation
- Protein Degradation and Inhibitors
- Cancer-related gene regulation
- Cancer therapeutics and mechanisms
Papers in
- Oncology 3
- Lung Cancer Research Studies 2
- Cancer-related Molecular Pathways 1
-
- Frailty in Older Adults 1
- Co-authors
- Charles M. Rudin (5 shared papers)Michelle A. Rudek (1 shared paper)Rosa Sebree (1 shared paper)James Gordon Herman (1 shared paper)Craig M. Hooker (1 shared paper)Salina D. Tsai (1 shared paper)Steven A. Belinsky (1 shared paper)John M. Wrangle (1 shared paper)
- Journals
- Journal of the American Geriatrics Society (1 paper)Cancer Discovery (1 paper)Cancer Research (1 paper)Molecular Cancer Research (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Sara C. Murphy
9 papers receiving 984 citations
Sara C. Murphy's Hit Papers
Peers
Comparison fields: 5 of 72
- Cancer Research 160
- Molecular Biology 738
- Oncology 267
- Immunology 85
- Genetics 31
Countries citing papers authored by Sara C. Murphy
This map shows the geographic impact of Sara C. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara C. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara C. Murphy more than expected).
Fields of papers citing papers by Sara C. Murphy
This network shows the impact of papers produced by Sara C. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara C. Murphy. The network helps show where Sara C. Murphy may publish in the future.
Co-authors
The 25 scholars most cited alongside Sara C. Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer Hit paper breakdown → | 2011 | 582 |
| 2 | 2008 | 182 | |
| 3 | 2011 | 143 | |
| 4 | 2013 | 56 | |
| 5 | 2013 | 32 | |
| 6 | 1999 | 5 | |
| 7 | 2023 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 |
About Sara C. Murphy
Sara C. Murphy is a scholar working on Oncology, Geriatrics and Gerontology, General Health Professions, Microbiology and Emergency Medical Services, having authored 9 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (2 papers), Cancer therapeutics and mechanisms (2 papers), Veterinary Oncology Research (1 paper), Cancer-related Molecular Pathways (1 paper), Cell death mechanisms and regulation (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Urban Transport and Accessibility (1 paper) and Frailty in Older Adults (1 paper). The work is most often cited by research in Cancer Research (160 citations), Molecular Biology (738 citations), Oncology (267 citations), Immunology (85 citations) and Genetics (31 citations). Sara C. Murphy has collaborated with scholars based in United States and Australia. Frequent co-authors include Charles M. Rudin, Michelle A. Rudek, Rosa Sebree, James Gordon Herman, Craig M. Hooker, Salina D. Tsai, Steven A. Belinsky, John M. Wrangle, Barbara Coleman and Frank P. Vendetti. Their work appears in journals such as Journal of the American Geriatrics Society, Cancer Discovery, Cancer Research, Molecular Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.